Axil Capital Advisors

Founder

Frederick Shane

Last edited by

#Employee

Approved Date

Jun 14, 2025

Asset Class

Venture Capital

Catalogue

Company Name Japanese

Axil Capital Advisors

Description English

Axil Capital Advisors is a Tokyo-based venture capital firm specializing in life sciences, investing from seed to crossover stages in areas such as biopharmaceuticals, medical devices, digital health, and healthcare services, with a focus on fostering global biotech innovation and creating synergies between Japan and international markets.

Description Japanese

Axil Capital Advisorsは、バイオ医薬品、医療機器、デジタルヘルス、ヘルスケアサービスなどライフサイエンス分野におけるシード〜クロスオーバーステージの企業に投資し、グローバルなバイオテック・イノベーションと日米連携の相乗効果を目指す東京拠点のベンチャーキャピタルです。

EMDB

Founded Year

2017

Style

Bio / Healthcare

162

Last edited time

Jun 26, 2025 09:21 AM GMT+0

Founder BIO

Fred Shane is a Managing Partner of Axil Capital. Fred heads the global investment team, and he is the portfolio manager for Axil’s global investments. Fred has played an integral role in co-founding and expanding Axil Capital from its inception in 2017. Fred is a seasoned investment professional with extensive experience in the VC, PE, and investment banking industries, where he has assumed a number of key positions at multiple prominent organizations. Prior to co-founding Axil, Fred was a Director in the Investment Business Department of Mizuho Securities. Prior to Mizuho, Fred was instrumental in setting up the biotech investment operations at Marubeni USA, where he gained deep experience in evaluating, executing and building value in biotech startups through the full lifecycle of the deal. Fred received his BS degree in Electrical Engineering & Computer Science from M.I.T.

Geography

Japan

Reviewed By

Hidekazu Ishida

URL